Follow
Mark Langowski
Mark Langowski
Unknown affiliation
Verified email at uw.edu
Title
Cited by
Cited by
Year
Modeling-enabled characterization of novel NLRX1 ligands
P Lu, R Hontecillas, V Abedi, S Kale, A Leber, C Heltzel, M Langowski, ...
PLoS One 10 (12), e0145420, 2015
342015
Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform
MD Langowski, FA Khan, AA Bitzer, CJ Genito, AJ Schrader, ML Martin, ...
Proceedings of the National Academy of Sciences 117 (6), 3114-3122, 2020
332020
Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum
MD Langowski, FA Khan, S Savransky, DR Brown, A Balasubramaniyam, ...
npj Vaccines 7 (1), 13, 2022
152022
Tobamovirus-based virus-like particles and vaccines
S Dutta, A Batchelor, F Khan, M Langowski
US Patent 11,285,204, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–4